Nimotuzumab suppresses epithelial–mesenchymal transition and enhances apoptosis in low-dose UV-C treated salivary adenoid cystic carcinoma cell lines in vitro-Reference-Cited by-同舟云学术

Nimotuzumab suppresses epithelial–mesenchymal transition and enhances apoptosis in low-dose UV-C treated salivary adenoid cystic carcinoma cell lines in vitro

Published:2014-10 Issue:9 Volume:25 Page:1052-1060
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Jiang Yang,Ge Xi-Yuan,Liu Shu-Ming,Zheng Lei,Huang Ming-Wei,Shi Yan,Fu Jia,Zhang Jian-Guo,Li Sheng-Lin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference36 articles.

1. Histologic grading of adenoid cystic carcinoma of the salivary glands.;Szanto;Cancer,1984

2. NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro.;Zhang;Cell Prolif,2009

3. Relationship of activated extracellular signal-regulated kinase 12 with lung metastasis in salivary adenoid cystic carcinoma.;Hu;Oncol Rep,2009

4. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.;Dodd;Oral Oncol,2006

5. . EGFR inhibition prevents in vitro tumor growth of salivary adenoid cystic carcinoma.;Huang;BMC Cell Biol,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Role of Epithelial–Mesenchymal Transition in Adenoid Cystic Carcinoma of the Salivary Glands: A Comprehensive Review;Cancers;2023-05-24

2. Overexpression of miR-651-5p inhibits ultraviolet radiation-induced malignant biological behaviors of sebaceous gland carcinoma cells by targeting ZEB2;Annals of Translational Medicine;2022-05

3. Nimotuzumab inhibits epithelial–mesenchymal transition in prostate cancer by targeting the Akt/YB‐1/AR axis;IUBMB Life;2019-03-25

4. The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands;Histochemistry and Cell Biology;2018-05-23

5. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial–Mesenchymal Transition Process;Anticancer Research;2017-07-05